Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1884 1
1978 2
1980 2
1981 3
1984 1
1985 1
1986 3
1987 2
1989 2
1990 4
1991 4
1992 1
1994 1
1995 3
1997 2
1998 1
1999 1
2000 6
2001 3
2002 5
2003 3
2004 8
2005 4
2006 5
2007 5
2008 3
2009 4
2010 4
2011 3
2012 3
2013 3
2014 3
2015 2
2016 3
2017 2
2018 2
2019 9
2020 1
2021 1
2022 3
Text availability
Article attribute
Article type
Publication date

Search Results

114 results
Results by year
Filters applied: . Clear all
Page 1
Immunological aspects of botulinum toxin therapy.
Dressler D, Bigalke H. Dressler D, et al. Among authors: bigalke h. Expert Rev Neurother. 2017 May;17(5):487-494. doi: 10.1080/14737175.2017.1262258. Epub 2016 Nov 28. Expert Rev Neurother. 2017. PMID: 27852103 Review.
Explorations in Guatemala.
Bigalke H. Bigalke H. Science. 1884 Feb 1;3(52):115-6. doi: 10.1126/science.ns-3.52.115-b. Science. 1884. PMID: 17768929 No abstract available.
Medical aspects of toxin weapons.
Bigalke H, Rummel A. Bigalke H, et al. Toxicology. 2005 Oct 30;214(3):210-20. doi: 10.1016/j.tox.2005.06.015. Epub 2005 Aug 8. Toxicology. 2005. PMID: 16087285 Review.
The immunology of botulinum toxin therapy: A brief summary.
Dressler D, Bigalke H, Frevert J. Dressler D, et al. Among authors: bigalke h. Toxicology. 2022 Nov;481:153341. doi: 10.1016/j.tox.2022.153341. Epub 2022 Sep 30. Toxicology. 2022. PMID: 36191878 Review.
[The pharmacology of botulinum toxin].
Bigalke H. Bigalke H. Med Monatsschr Pharm. 2002 Sep;25(9):305-8. Med Monatsschr Pharm. 2002. PMID: 12369431 Review. German. No abstract available.
Long-term adherence and response to botulinum toxin in different indications.
Lee JI, Jansen A, Samadzadeh S, Kahlen U, Moll M, Ringelstein M, Soncin G, Bigalke H, Aktas O, Moldovan AS, Waskoenig J, Jander S, Gliem M, Schnitzler A, Hartung HP, Hefter H, Albrecht P. Lee JI, et al. Among authors: bigalke h. Ann Clin Transl Neurol. 2021 Jan;8(1):15-28. doi: 10.1002/acn3.51225. Epub 2020 Dec 1. Ann Clin Transl Neurol. 2021. PMID: 33259153 Free PMC article.
Botulinum neurotoxin - from laboratory to bedside.
Foster KA, Bigalke H, Aoki KR. Foster KA, et al. Among authors: bigalke h. Neurotox Res. 2006 Apr;9(2-3):133-40. doi: 10.1007/BF03033931. Neurotox Res. 2006. PMID: 16785110 Review.
114 results